Ethylene glycol poisoning
diseaseOn this page
Summary
Ethylene glycol poisoning (MONDO:0017861) is a disease. A subtype of poisoning — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: Unknown (Worldwide)
- Phenotypes (HPO): 44
Clinical features
Signs & symptoms
Clinical features (HPO)
44 HPO clinical features (Orphanet curated; top 44 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0001942 | Metabolic acidosis | Very frequent (80-99%) |
| HP:0003128 | Lactic acidosis | Very frequent (80-99%) |
| HP:0001251 | Ataxia | Frequent (30-79%) |
| HP:0001289 | Confusion | Frequent (30-79%) |
| HP:0001350 | Slurred speech | Frequent (30-79%) |
| HP:0001649 | Tachycardia | Frequent (30-79%) |
| HP:0002013 | Vomiting | Frequent (30-79%) |
| HP:0002018 | Nausea | Frequent (30-79%) |
| HP:0002329 | Drowsiness | Frequent (30-79%) |
| HP:0002789 | Tachypnea | Frequent (30-79%) |
| HP:0002901 | Hypocalcemia | Frequent (30-79%) |
| HP:0031844 | Euphoria | Frequent (30-79%) |
| HP:0031962 | Elevated serum anion gap | Frequent (30-79%) |
| HP:0000083 | Renal insufficiency | Occasional (5-29%) |
| HP:0000822 | Hypertension | Occasional (5-29%) |
| HP:0000961 | Cyanosis | Occasional (5-29%) |
| HP:0001259 | Coma | Occasional (5-29%) |
| HP:0001635 | Congestive heart failure | Occasional (5-29%) |
| HP:0001657 | Prolonged QT interval | Occasional (5-29%) |
| HP:0002153 | Hyperkalemia | Occasional (5-29%) |
| HP:0002315 | Headache | Occasional (5-29%) |
| HP:0002615 | Hypotension | Occasional (5-29%) |
| HP:0002793 | Abnormal pattern of respiration | Occasional (5-29%) |
| HP:0004885 | Episodic respiratory distress | Occasional (5-29%) |
| HP:0005110 | Atrial fibrillation | Occasional (5-29%) |
| HP:0005263 | Gastritis | Occasional (5-29%) |
| HP:0007695 | Abnormal pupillary light reflex | Occasional (5-29%) |
| HP:0030955 | Alcoholism | Occasional (5-29%) |
| HP:0031273 | Shock | Occasional (5-29%) |
| HP:0100598 | Pulmonary edema | Occasional (5-29%) |
| HP:0000124 | Renal tubular dysfunction | Very rare (<1-4%) |
| HP:0000602 | Ophthalmoplegia | Very rare (<1-4%) |
| HP:0000639 | Nystagmus | Very rare (<1-4%) |
| HP:0000790 | Hematuria | Very rare (<1-4%) |
| HP:0001250 | Seizure | Very rare (<1-4%) |
| HP:0001298 | Encephalopathy | Very rare (<1-4%) |
| HP:0001336 | Myoclonus | Very rare (<1-4%) |
| HP:0002045 | Hypothermia | Very rare (<1-4%) |
| HP:0002181 | Cerebral edema | Very rare (<1-4%) |
| HP:0008682 | Renal tubular epithelial necrosis | Very rare (<1-4%) |
| HP:0010628 | Facial palsy | Very rare (<1-4%) |
| HP:0011037 | Decreased urine output | Very rare (<1-4%) |
| HP:0030157 | Flank pain | Very rare (<1-4%) |
| HP:0031910 | Abnormal cranial nerve physiology | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | ethylene glycol poisoning |
| Mondo ID | MONDO:0017861 |
| Orphanet | 31826 |
| SNOMED CT | 426692001 |
| GARD | 0018805 |
| Is cancer (heuristic) | no |
Disease family
This is a subtype of poisoning. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › poisoning › ethylene glycol poisoning
Related subtypes (58): toxic oil syndrome, infantile mercury poisoning, ketamine-induced biliary dilatation, manganese poisoning, cyanide-induced parkinsonism, colchicine poisoning, methanol poisoning, paraquat poisoning, lead poisoning, mercury poisoning, acute opioid poisoning, acute tricyclic antidepressant poisoning, acute poisoning by drugs with membrane-stabilizing effect, snakebite envenomation, paracetamol poisoning, cyanide poisoning, scorpion envenomation, argyria, acute ackee fruit intoxication, cocaine intoxication, systemic monochloroacetate poisoning, water intoxication, cassavism, formaldehyde poisoning, heavy metal poisoning, abacavir toxicity, allopurinol toxicity, codeine toxicity, efavirenz toxicity, flucloxacilline toxicity, isoniazid toxicity, raltegravir toxicity, voriconazole toxicity, curariform drugs toxicity, statin toxicity, phenytoin or carbamazepine toxicity, letrozole toxicity, ricin poisoning, ivermectin toxicity, belinostat toxicity or dose selection, toxicity to dolutegravir, mycotoxicosis, ciguatera fish poisoning, lathyrism, cadmium poisoning, phenytoin toxicity, nerve agent poisoning, local anesthetic poisoning, fire ant poisoning, aflatoxicosis, black widow spider envenomation, platinum-induced ototoxicity, carbon monoxide poisoning, organophosphate poisoning, sulfur mustard poisoning, cardiac glycoside intoxication, monochloroacetic acid poisoning, chemotherapy-induced toxicity
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.